CLBCX
Price
$39.50
Change
+$0.07 (+0.18%)
Updated
Nov 12 closing price
Net Assets
268.19B
MBACX
Price
$31.99
Change
+$0.08 (+0.25%)
Updated
Nov 12 closing price
Net Assets
449.63M
Interact to see
Advertisement

CLBCX vs MBACX

Header iconCLBCX vs MBACX Comparison
Open Charts CLBCX vs MBACXBanner chart's image
American Funds American Balanced 529C
Price$39.50
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets268.19B
NYLI Balanced
Price$31.99
Change+$0.08 (+0.25%)
VolumeN/A
Net Assets449.63M
CLBCX vs MBACX Comparison Chart in %
View a ticker or compare two or three
VS
CLBCX vs. MBACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and MBACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 268B vs. MBACX (450M). CLBCX pays higher dividends than MBACX: CLBCX (1.04) vs MBACX (0.88). CLBCX was incepted earlier than MBACX: CLBCX (24 years) vs MBACX (23 years). MBACX (2.20) is less costly to investors than CLBCX (1.35). MBACX is a more actively managed with annual turnover of: 230.00 vs. CLBCX (44.00). CLBCX has a lower initial minimum investment than MBACX: CLBCX (250) vs MBACX (1000). CLBCX annual gain was more profitable for investors over the last year : 9.13 vs. MBACX (0.98). CLBCX return over 5 years is better than : 37.82 vs. MBACX (5.46).
CLBCXMBACXCLBCX / MBACX
Total Expense Ratio1.352.0965%
Annual Report Gross Expense Ratio1.352.2061%
Fund Existence24 years23 years-
Gain YTD15.4618.147190%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets268B450M59,556%
Annual Yield % from dividends1.040.88118%
Returns for 1 year9.130.98934%
Returns for 3 years41.0016.20253%
Returns for 5 years37.825.46693%
Returns for 10 years76.856.821,128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE23.430.08
+0.34%
Spyre Therapeutics
ATLCP24.18-0.02
-0.08%
Atlanticus Holdings Corp
CVGW22.13-0.13
-0.58%
Calavo Growers
CNM49.11-0.99
-1.98%
Core & Main
UFI3.58-0.12
-3.24%
UNIFI